Sandra Dillon
Myelofibrosis Patient and Advocate
Sandra Dillon was diagnosed with an aggressive form of myelofibrosis in 2016 in her late 20s. She showed good response on a clinical trial of fedratinib through Dr. Catriona Jamieson at Moores Cancer Center in San Diego, but the trial was halted. Watch the video with Sandra to learn how she was able to regain access to her initial treatment.
